IFBD NASDAQ Week ended 07 Aug 2026

Weekly Investor Report

Infobird Co Ltd · Technology · Software - Application

Open interactive chart View report data
Latest close 1.08 USD
3.8% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 10.1% above the Trend Line and sits at 27.7% of its 52-week range. The latest completed week returned 3.8%, after a -10.7% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 48/100. Near-term considerations: volume confirmation is below normal.

Setup score 27 out of 100
Latest Close 1.08 USD 7 Aug 2026
1W Return 3.8% latest completed week
4W Return -10.7% short-term follow-through
12W Return 25.6% quarterly tape
Trend Breadth 17.3% 9 of 52 weeks active
Volume Ratio 0.1x vs 13-week average
What is working
  • The trend backdrop is active with a 8-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 35.77% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 3.8% Latest completed week; four-week move -10.7%. Indicator stack 37/63 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 35.77% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 48/100 33 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 10.1% above the Trend Line and sits at 27.7% of its 52-week range. The latest completed week returned 3.8%, after a -10.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.1x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4112-week average 0.24

12-week confirmation

Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.41Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -10.7% over four weeks, 25.6% over 12 weeks, and 5.9% over one year. The current trend has remained active for 8 consecutive weeks.

Performance by holding period

1W3.8%
4W-10.7%
12W25.6%
26W54.3%
52W5.9%
Active trend streak8 weeks
Active weeks in one year9
Trend breadth17.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.77Latest activity-pressure read.
Pressure change-5.5%Four-week change in activity pressure.
Leadership-6.98Latest relative-leadership reading.
RS change-385.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 79% Model confidence 74%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength58/100Blend of value, momentum, and quality. Underlying universe rank 43; rank 1 is best.
Value54/100Relative valuation strength. Underlying universe rank 47; rank 1 is best.
Quality51/100Profitability and accounting quality. Underlying universe rank 50; rank 1 is best.
Momentum53/100Medium-term price momentum. Underlying universe rank 48; rank 1 is best.
Growth53/100Revenue and earnings growth. Underlying universe rank 48; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
1.0x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-7.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
29.5%
Gross profit retained from each unit of revenue.
Operating margin
-651.2%
Operating profit retained from revenue.
Free-cash-flow margin
-6.0%
Free cash flow generated from revenue.
Return on invested capital
-356.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment48/100

Weighted news tone is neutral across 33 relevant articles.

3 positive · 24 neutral · 6 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-50.3%Distance below the 52-week high.
13-week volatility7.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+47.1%Week of 13 Feb.
Worst week-9.5%Week of 15 May.
Latest week+3.8%Week of 7 Aug.

Shape of recent returns

Strong gains8
Modest gains5
Flat weeks0
Modest losses6
Sharp losses7
Recent vol7.7%13-week weekly-return volatility.
Base vol10.1%52-week weekly-return volatility.
Up/down split21/31Count of positive and negative weeks in the 52-week window.
Average skew9.1% / -5.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape27/100

Trend, activity pressure, participation, and risk combine to a 27/100 tape read.

 Indicator analysis55/100

Latest 12-week confirmation: trend 8/12, activity pressure 11/12, relative leadership 2/12.

Activity pressure 0.41; No reversal markers Next-Week ExpectancyNegative 35.77%

Next-week expectancy is negative with a 35.77% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors53/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 48 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment48/100

Weighted news tone is neutral across 33 relevant articles.

IFBD|Infobird Co Ltd|Price:1.075|Chg%:-0.035 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20261.08 USD3.8%0.98 USD4.49 USD0.77-6.9843.4KOn
31 Jul 20261.04 USD-2.8%0.98 USD5.12 USD0.94-6.1839.4KOn
24 Jul 20261.07 USD-7.0%0.98 USD5.89 USD1.05-3.2714.1KOn
17 Jul 20261.15 USD-5.0%0.98 USD7.00 USD0.961.9442.2KOn
10 Jul 20261.21 USD5.2%0.97 USD7.98 USD0.822.4497.4KOn
3 Jul 20261.15 USD17.3%0.96 USD8.88 USD0.62-1.0884.4KOn
26 Jun 20260.98 USD-9.3%0.96 USD9.95 USD0.32-15.2639.0KOn
19 Jun 20261.08 USD9.2%0.96 USD11.20 USD0.22-11.3748.9KOn
12 Jun 20260.99 USD7.5%0.95 USD12.78 USD0.03-17.132.8MOff
5 Jun 20260.92 USD1.1%0.96 USD14.29 USD-0.06-21.7380.7KOff
29 May 20260.91 USD-1.6%0.97 USD15.77 USD0.16-26.721.9MOff
22 May 20260.93 USD7.5%0.98 USD17.11 USD0.35-23.9922.2KOff
15 May 20260.86 USD-9.5%0.99 USD18.35 USD0.59-29.0615.9KOff
8 May 20260.95 USD-3.4%0.99 USD19.59 USD0.75-22.727.3KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context